Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

SM 13496

Known as: SM13496, SM-13496, 13496, SM 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Lurasidone Hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
ACS chemical neuroscience molecule spotlight on latuda (lurasidone; SM-13,496).
  • C. Hopkins
  • ACS chemical neuroscience
  • 2011
  • Corpus ID: 30568993
S chizophrenia is a chronic and extremely severe disorder of the mind and brain that affects approximately 1% of the population… 
Highly Cited
2010
Highly Cited
2010
Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity
Lurasidone [(3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylmethyl]cyclohexylmethyl}hexahydro-4,7-methano… 
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2007
Highly Cited
2007
Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test.
Lurasidone (SM-13496) is a novel atypical antipsychotic with high affinities to dopamine D2, serotonin 5-HT7, 5-HT2A, 5-HT1A… 
1999
1999
In vitro binding profile of SM-13496, a novel atypical antipsychotic agent
1997
1997
Behavioral characteristics of SM-13496, a novel atypical antipsychotic agent
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE